Xperi Holding Corporation Announces First Quarter 2022 Results
Xperi Holding Corporation (NASDAQ: XPER) reported first quarter 2022 revenue of $257.4 million, a 16% increase from $221.6 million in Q1 2021, driven by a Micron agreement. GAAP earnings per share rose to $0.24 from $0.05 year-over-year. The company reaffirmed its full-year revenue outlook of $910M to $950M. Key highlights included licensing agreements with major players like Micron and BMW, and increased product revenues from IPTV and consumer electronics. Xperi is on track to separate its product and IP businesses in the fall for potential long-term value creation.
- Revenue increased by 16% to $257.4 million compared to Q1 2021.
- GAAP EPS improved to $0.24 from $0.05 year-over-year.
- Cash flow from operations rose to $46.3 million, up from $26.7 million in Q1 2021.
- Successful licensing agreements, including Micron for Adeia's semiconductor portfolio, covering over 90% of the DRAM market.
- Operating expenses projected to range between $725 million to $755 million, which may pressure profits.
Remains on track to separate product and IP businesses in the fall
“We are off to a good start for the year, delivering revenue growth of
First Quarter 2022 Financial Highlights:
-
Revenue of
for the quarter, increased$257.4 million 16% compared to for Q1 2021.$221.6 million -
GAAP earnings per share of
, compared to$0.24 in Q1 2021, and non-GAAP earnings per share of$0.05 , compared to$0.92 in Q1 2021.$0.59 -
Cash Flow from Operations was
, versus$46.3 million in Q1 2021.$26.7 million -
Repurchased
of common stock.$17.3 million
First Quarter 2022 Business and Recent Operating Highlights:
IP Licensing Business (Revenue:
- A top 10 virtual Multichannel Video Programming Distributor (vMVPD) entered into a long-term license renewal for Adeia’s media patent portfolios.
-
LAPIS Technology, a
ROHM Semiconductor Group subsidiary, entered into an agreement for access to Adeia’s DBI® Ultra die-to-wafer hybrid bonding technology and foundational hybrid bonding patent portfolio. -
Micron entered into a license for Adeia’s hybrid bonding and semiconductor portfolio, resulting in Adeia now having more than
90% of the DRAM memory market under license.
Product Business (Revenue:
Pay-TV highlights:
- Continued to drive adoption of higher-value IPTV solutions, with double-digit IPTV subscriber growth as compared to the fourth quarter.
-
Added new operators with our expanded product offerings, including a new win with
NfinityLink Communications .
Consumer Electronics highlights:
- Signed key renewals with Skyworth and Best Buy relating to soundbar and TV products.
- Expanded licensing relationship with TCL to include decoder post-processing and DTS Play-Fi support in soundbar and TV products.
- Achieved DXOMARK’s #1 ranking for the latest IMAX Enhanced certified mobile device from Honor.1
-
DTS Headphone:X-enabled headphones from HyperX were recognized as Editors’ Pick for “Best Gaming Headsets” by
Rolling Stone magazine .
Connected Car highlights:
- BMW expanded shipments of the iX model with DTS AutoSense into more countries, and we advanced engagement for in-cabin monitoring solutions with numerous European and Asian car companies.
-
Mercedes-Benz expanded shipments of DTS AutoStage-enabled models to more than 40 countries, and over the quarter we further advanced pipeline development for DTS AutoStage with OEM customers in the
U.S. ,Europe , andAsia . -
DTS AutoSense Neuromorphic Driver Monitoring Solution was a 2022 Winner for the Artificial Intelligence Excellence Award presented by the
Business Intelligence Group .
Media Platform highlights:
-
Strengthened customers’ premium live TV viewing experience by integrating YouTube TV into TiVo Stream OS and
TiVo Stream 4K. - Launched TiVo Xtend™, an end-to-end advertising solution that enables incremental reach and frequency opportunities for Connected TV advertisers.
- Added streaming services Shudder, SundanceNow, and allblk to TiVo Stream OS, increasing on-platform ad-supported viewership.
-
Advanced
TiVo Stream ecosystem development across content partners, OEMs, and chipset providers.
1 DXOMARK is an independent benchmark site that scientifically assesses smartphones, lenses, and cameras.
Capital Allocation
During the quarter, the Company repurchased
On
On
Financial Outlook
The Company reiterates its full year 2022 outlook:
Category |
GAAP Outlook |
Non-GAAP Outlook |
Revenue |
|
|
COGS |
|
|
Operating Expense excluding COGS* |
|
|
Interest Expense |
~ |
~ |
Other Income |
~ |
~ |
Cash Tax (net of refunds) |
|
|
Basic Shares Outstanding |
105M |
105M |
Diluted Shares Outstanding |
107M |
113M |
Operating Cash Flow |
|
|
*See tables for reconciliation of GAAP to non-GAAP differences.
Conference Call Information
The Company will hold its first quarter 2022 earnings conference call at
Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company’s financial results, forecasts, and business outlook, and anticipated business separation timing. In this context, forward-looking statements often address expected future business, financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “could,” “seek,” “see,” “will,” “may,” “would,” “might,” “potentially,” “estimate,” “continue,” “expect,” “target,” similar expressions or the negatives of these words or other comparable terminology that convey uncertainty of future events or outcomes. All forward-looking statements by their nature address matters that involve risks and uncertainties, many of which are beyond our control, and are not guarantees of future results, such as statements about the anticipated benefits of the transaction. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in such statements and, therefore, you should not place undue reliance on any such statements and caution must be exercised in relying on forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenue, cost savings, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business strategies, and expansion and growth of the Company’s businesses; the Company’s ability to implement its business strategy; pricing trends, including the Company’s ability to achieve economies of scale; the ability of the Company to retain and hire key personnel; uncertainty as to the long-term value of the Company’s common stock; legislative, regulatory and economic developments affecting the Company’s business; general economic and market developments and conditions; failure to remediate the material weaknesses in our internal control over financial reporting; the evolving legal, regulatory and tax regimes under which the 4 Company operates; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, including Russia’s invasion of
About
Non-GAAP Financial Measures
In addition to disclosing financial results calculated in accordance with
Set forth below are reconciliations of the Company’s reported and forecasted GAAP to non-GAAP financial metrics.
SOURCE:
XPER-E
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||
(in thousands, except per share amounts) | |||||||||
(unaudited) | |||||||||
Three Months Ended | |||||||||
2022 |
2021 |
||||||||
Revenue | $ |
257,420 |
|
$ |
221,596 |
|
|||
Operating expenses: | |||||||||
Cost of revenue, excluding depreciation and amortization of intangible assets |
|
27,697 |
|
|
28,132 |
|
|||
Research, development and other related costs |
|
59,370 |
|
|
55,223 |
|
|||
Selling, general and administrative |
|
70,446 |
|
|
67,430 |
|
|||
Depreciation expense |
|
5,866 |
|
|
5,684 |
|
|||
Amortization expense |
|
39,319 |
|
|
52,195 |
|
|||
Litigation expense |
|
1,753 |
|
|
2,533 |
|
|||
Total operating expenses |
|
204,451 |
|
|
211,197 |
|
|||
Operating income |
|
52,969 |
|
|
10,399 |
|
|||
Interest expense |
|
(8,429 |
) |
|
(11,313 |
) |
|||
Other income (expense), net |
|
968 |
|
|
1,425 |
|
|||
Income before taxes |
|
45,508 |
|
|
511 |
|
|||
Provision for (benefit from) income taxes |
|
21,533 |
|
|
(4,015 |
) |
|||
Net income | $ |
23,975 |
|
$ |
4,526 |
|
|||
Less: net loss attributable to noncontrolling interest |
|
(968 |
) |
|
(761 |
) |
|||
Net income attributable to the Company | $ |
24,943 |
|
$ |
5,287 |
|
|||
Income per share attributable to the Company: | |||||||||
Basic | $ |
0.24 |
|
$ |
0.05 |
|
|||
Diluted | $ |
0.24 |
|
$ |
0.05 |
|
|||
Weighted average number of shares used in per share calculations-basic |
|
103,679 |
|
|
104,940 |
|
|||
Weighted average number of shares used in per share calculations-diluted |
|
105,332 |
|
|
107,776 |
|
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(in thousands) | ||||||||
(unaudited) | ||||||||
|
2022 |
|
|
2021 |
|
|||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ |
214,095 |
|
$ |
201,121 |
|
||
Available-for-sale debt securities |
|
52,720 |
|
|
60,534 |
|
||
Accounts receivable, net |
|
100,203 |
|
|
143,683 |
|
||
Unbilled contracts receivable, net |
|
121,778 |
|
|
77,677 |
|
||
Other current assets |
|
42,737 |
|
|
36,459 |
|
||
Total current assets |
|
531,533 |
|
|
519,474 |
|
||
Long-term unbilled contracts receivable |
|
43,112 |
|
|
4,107 |
|
||
Property and equipment, net |
|
59,251 |
|
|
60,974 |
|
||
Operating lease right-of-use assets |
|
65,513 |
|
|
68,498 |
|
||
Intangible assets, net |
|
778,680 |
|
|
817,916 |
|
||
|
850,100 |
|
|
851,088 |
|
|||
Other long-term assets |
|
150,641 |
|
|
147,965 |
|
||
Total assets | $ |
2,478,830 |
|
$ |
2,470,022 |
|
||
LIABILITIES AND EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ |
11,835 |
|
$ |
7,811 |
|
||
Accrued liabilities |
|
99,540 |
|
|
110,705 |
|
||
Current portion of long-term debt, net |
|
36,152 |
|
|
36,095 |
|
||
Deferred revenue |
|
48,913 |
|
|
35,136 |
|
||
Total current liabilities |
|
196,440 |
|
|
189,747 |
|
||
Deferred revenue, less current portion |
|
34,128 |
|
|
37,107 |
|
||
Long-term deferred tax liabilities |
|
19,085 |
|
|
19,848 |
|
||
Long-term debt, net |
|
720,333 |
|
|
729,392 |
|
||
Noncurrent operating lease liabilities |
|
51,930 |
|
|
54,658 |
|
||
Other long-term liabilities |
|
102,267 |
|
|
98,842 |
|
||
Total liabilities |
|
1,124,183 |
|
|
1,129,594 |
|
||
Commitments and contingencies | ||||||||
Company stockholders’ equity: | ||||||||
Preferred stock |
|
— |
|
|
— |
|
||
Common stock |
|
116 |
|
|
113 |
|
||
Additional paid-in capital |
|
1,365,277 |
|
|
1,340,480 |
|
||
|
(206,350 |
) |
|
(178,022 |
) |
|||
Accumulated other comprehensive loss |
|
(1,766 |
) |
|
(752 |
) |
||
Retained earnings |
|
207,539 |
|
|
187,814 |
|
||
|
1,364,816 |
|
|
1,349,633 |
|
|||
Noncontrolling interest |
|
(10,169 |
) |
|
(9,205 |
) |
||
Total equity |
|
1,354,647 |
|
|
1,340,428 |
|
||
Total liabilities and equity | $ |
2,478,830 |
$ |
2,470,022 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(in thousands) | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
Cash flows from operating activities: | ||||||||
Net income | $ |
23,975 |
|
$ |
4,526 |
|
||
Adjustments to reconcile net income to net cash from operating activities: | ||||||||
Depreciation of property and equipment |
|
5,866 |
|
|
5,684 |
|
||
Amortization of intangible assets |
|
39,319 |
|
|
52,195 |
|
||
Stock-based compensation expense |
|
16,804 |
|
|
13,219 |
|
||
Deferred income taxes |
|
(911 |
) |
|
666 |
|
||
Other |
|
1,984 |
|
|
3,217 |
|
||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable |
|
43,698 |
|
|
(7,632 |
) |
||
Unbilled contracts receivable |
|
(82,995 |
) |
|
2,295 |
|
||
Other assets |
|
(8,806 |
) |
|
(10,697 |
) |
||
Accounts payable |
|
4,024 |
|
|
11,429 |
|
||
Accrued and other liabilities |
|
(7,483 |
) |
|
(45,687 |
) |
||
Deferred revenue |
|
10,798 |
|
|
(2,486 |
) |
||
Net cash from operating activities |
|
46,273 |
|
|
26,729 |
|
||
Cash flows from investing activities: | ||||||||
Purchases of property and equipment |
|
(4,289 |
) |
|
(1,772 |
) |
||
Proceeds from sale of property and equipment |
|
— |
|
|
5 |
|
||
Purchases of intangible assets |
|
(180 |
) |
|
(36 |
) |
||
Purchases of short-term investments |
|
(4,490 |
) |
|
(42,505 |
) |
||
Proceeds from sales of investments |
|
2,000 |
|
|
16,921 |
|
||
Proceeds from maturities of investments |
|
10,023 |
|
|
10,000 |
|
||
Net cash from investing activities |
|
3,064 |
|
|
(17,387 |
) |
||
Cash flows from financing activities: | ||||||||
Dividends paid |
|
(5,218 |
) |
|
(5,264 |
) |
||
Repayment of debt |
|
(10,125 |
) |
|
(13,125 |
) |
||
Proceeds from employee stock purchase program and exercise of stock options |
|
8,000 |
|
|
6,715 |
|
||
Repurchases of common stock |
|
(28,328 |
) |
|
(32,359 |
) |
||
Net cash from financing activities |
|
(35,671 |
) |
|
(44,033 |
) |
||
Effect of exchange rate changes on cash and cash equivalents |
|
(692 |
) |
|
(738 |
) |
||
Net increase (decrease) in cash and cash equivalents |
|
12,974 |
|
|
(35,429 |
) |
||
Cash and cash equivalents at beginning of period |
|
201,121 |
|
|
170,188 |
|
||
Cash and cash equivalents at end of period | $ |
214,095 |
|
$ |
134,759 |
|
||
Supplemental disclosure of cash flow information: | ||||||||
Interest paid | $ |
7,188 |
|
$ |
9,015 |
|
||
Income taxes paid, net of refunds | $ |
3,334 |
|
$ |
5,921 |
|
GAAP TO NON-GAAP RECONCILIATIONS | |||||
(in thousands, except per share amounts) | |||||
(unaudited) | |||||
Net income attributable to the Company: | |||||
Three Months Ended | |||||
GAAP net income attributable to the Company | $ |
24,943 |
|
||
Adjustments to GAAP net income attributable to the Company: | |||||
Stock-based compensation expense: | |||||
Cost of revenue |
|
628 |
|
||
Research, development and other |
|
5,475 |
|
||
Selling, general and administrative |
|
10,701 |
|
||
Amortization expense |
|
39,319 |
|
||
Merger and integration-related costs: | |||||
Transaction and other related costs recorded in selling, general and administrative |
|
172 |
|
||
Severance and retention recorded in cost of revenue, excluding depreciation and amortization of intangible assets |
|
144 |
|
||
Severance and retention recorded in research, development and other |
|
290 |
|
||
Severance and retention recorded in selling, general and administrative |
|
28 |
|
||
Separation costs recorded in selling, general and administrative |
|
2,780 |
|
||
Tax provision recorded in excess of cash taxes paid |
|
18,199 |
|
||
Non-GAAP net income attributable to the Company | $ |
102,679 |
|
||
Diluted earnings per share attributable to the Company: | |||||
Three Months Ended | |||||
GAAP diluted income per share attributable to the Company | $ |
0.24 |
|
||
Adjustments to GAAP diluted income per share attributable to the Company: | |||||
Stock-based compensation expense |
|
0.16 |
|
||
Amortization expense |
|
0.37 |
|
||
Merger and integration-related costs |
|
0.01 |
|
||
Separation costs |
|
0.03 |
|
||
Difference in shares used in the calculation |
|
(0.06 |
) |
||
Tax provision recorded in excess of cash taxes paid |
|
0.17 |
|
||
Non-GAAP diluted earnings per share attributable to the Company | $ |
0.92 |
|
||
Weighted average number of shares used in per share calculations excluding the effects of stock-based compensation - diluted |
|
111,649 |
|
RECONCILIATION FOR GUIDANCE ON | ||||||||
GAAP TO NON-GAAP OPERATING EXPENSE EXCLUDING COGS | ||||||||
(in millions) | ||||||||
(unaudited) | ||||||||
Twelve Months Ended | ||||||||
Low | High | |||||||
GAAP operating expense excluding COGS | $ |
725.0 |
|
$ |
755.0 |
|
||
Stock-based compensation -- R&D |
|
(23.0 |
) |
|
(23.0 |
) |
||
Stock-based compensation -- SG&A |
|
(39.0 |
) |
|
(39.0 |
) |
||
Merger, integration and separation-related expense -- SG&A |
|
(15.0 |
) |
|
(15.0 |
) |
||
Amortization expense |
|
(158.0 |
) |
|
(158.0 |
) |
||
Total of non-GAAP adjustments |
|
(235.0 |
) |
|
(235.0 |
) |
||
Non-GAAP operating expense excluding COGS | $ |
490.0 |
|
$ |
520.0 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005975/en/
Xperi Investor Contact:
+1 203-832-4449
ir@xperi.com
Media Contact:
+1 949-518-6846
amy.brennan@xperi.com
Source:
FAQ
What were Xperi's first quarter 2022 earnings results?
What is the full-year revenue outlook for Xperi in 2022?
What major licensing agreements did Xperi announce in Q1 2022?
How much common stock did Xperi repurchase in Q1 2022?